SLIDESHOW: Ten Bargains You Can Buy Cheaper Than The Insiders
| This Slide: #1 of 10 |
(1) Eiger BioPharmaceuticals Inc (NASDAQ:EIGR) triggered: 01/23/2020
Eiger BioPharmaceuticals is a clinical stage biopharmaceutical company focused on bringing to market product candidates for the treatment of rare diseases. Co.'s product candidate pipeline includes four programs: Lonafarnib (LNF) in Hepatitis Delta Virus (HDV), which is an orally bioavailable, farnesylation inhibitor in Phase 3 clinical trials for HDV infection; Peginterferon Lambda in HDV, which is a late-stage, type III interferon that stimulates immune responses; LNF in Progeria and Progeroid Laminopathies (PL), which Co. develops LNF for treatment of PL; and Avexitide in Post-Bariatric Hypoglycemia (PBH), which is a peptide that Co. is developing as a treatment for PBH.
EIGR — last trade: $12.905 — Recent Insider Buys:
| Purchased | Insider | Title | Shares | Price/Share | Value |
|---|---|---|---|---|---|
| 01/10/2020 | Thomas John Dietz | Director | 4,000 | $13.94 | $55,760 |
|
|||||||||||||||||||||
Read full article in a new window: Pick Up This Bargain Even Cheaper Than Director Dietz Did
Open the EIGR Videos Page (in a new window) »
|
|
Avg. Broker Rec.
|
Strong Buy (4.00 out of 4) 94th percentile
(ranked higher than approx. 94% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |
|
|
